As of April 16, 2025, Akero Therapeutics (AKRO) has a market cap of $3.03 billion USD. According to our data, Akero Therapeutics is ranked No.3328 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $3.03 B |
42.97%
|
Dec 31, 2024 | $2.12 B |
19.14%
|
Dec 29, 2023 | $1.78 B |
-57.39%
|
Dec 30, 2022 | $4.18 B |
159.10%
|
Dec 31, 2021 | $1.61 B |
-18.02%
|
Dec 31, 2020 | $1.97 B |
16.24%
|
Dec 31, 2019 | $1.69 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Madrigal Pharmaceuticals
MDGL
|
$7.09 B |
-0.000 M
|
![]() USA
|
![]() Viking Therapeutics
VKTX
|
$2.59 B |
-0.000 M
|
![]() USA
|
![]() Galmed Pharmaceuticals
GLMD
|
$3.18 M |
0.000 M
|
![]() Israel
|
![]() Seabridge Gold
SA
|
$1.25 B |
0.000 M
|
![]() Canada
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Enanta Pharmaceuticals
ENTA
|
$0.11 B |
-0.000 M
|
![]() USA
|
![]() 89bio
ETNB
|
$0.88 B |
-0.000 M
|
![]() USA
|
![]() Arbutus Biopharma
ABUS
|
$0.61 B |
-0.000 M
|
![]() USA
|
Market Cap | = | AKRO Stock Price | * | AKRO Shares Outstanding |
= | $38.08 | * | 79.62 M | |
= | $3.03 B |